Usami, E., Kimura, M., Takenaka, S., Iwai, M., Teramachi, H., & Yoshimura, T. (2019). Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myeloma. Mol Clin Oncol.
Dyfyniad Arddull ChicagoUsami, Eiseki, Michio Kimura, Shoya Takenaka, Mina Iwai, Hitomi Teramachi, and Tomoaki Yoshimura. "Tolerability and Safety of Real-world Use of Pomalidomide in Patients With Relapsed/refractory Multiple Myeloma." Mol Clin Oncol 2019.
Dyfyniad MLAUsami, Eiseki, et al. "Tolerability and Safety of Real-world Use of Pomalidomide in Patients With Relapsed/refractory Multiple Myeloma." Mol Clin Oncol 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.